Medicare Advantage Pullback Affects 638,000 Beneficiaries Across 16 States
A new analysis from KFF reveals that residents of 193 counties will have no Medicare Advantage prescription drug (MA-PD) plan available for general enrollment in 2027—a sharp increase from 123 counties in 2026. This sudden pullback affects roughly 638,000 Medicare beneficiaries across 16 states.
In this interview, Robert Powell, CFP®, sits down with Jae Oh, CFP®, author of “Maximize Your Medicare,” to unpack what this market contraction means for affected retirees and explain the critical federal safety nets in place.
Key Discussion Points
- 00:00 – Introduction: The KFF County-Level Analysis
- 01:10 – 193 Counties Affected: Why Insurers Are Pulling Back
- 02:25 – The Federal Safety Net: Guaranteed-Issue Medigap Acceptance
- 03:55 – Why Original Medicare Alone Leaves You Exposed to Uncapped Medical Bills
- 05:20 – Overlooked Prescription Relief: The “Extra Help” (LIS) Program
- 07:00 – Deadlines & Notices: Why You Have Until December 31 to Pick a Replacement
- 08:40 – Navigating the Medicare.gov Plan Finder
Key Strategic Takeaways
- The 193-County Desert: KFF data shows a 57% increase in counties with zero general-enrollment MA-PD plans, concentrated across rural areas in 16 states.
- Guaranteed-Issue Rights: If your Medicare Advantage plan withdraws from your county, federal regulations guarantee you the right to purchase certain Medigap policies without medical underwriting or denial for pre-existing conditions.
- Beware Uncapped Costs: Returning solely to Original Medicare (Part A and Part B) leaves you exposed with no annual out-of-pocket maximum, making a Medigap policy and standalone Part D essential.
- The Dec. 31 Exception: While general open enrollment closes Dec. 7, enrollees whose plans terminate at year-end receive an extended window through Dec. 31 to finalize standalone Part D drug coverage.
Subscribe to stay informed on retirement planning, Medicare optimization, and Social Security strategies.
